Philip M. Batista, MD
Cooper University Health Care announced today that it is the first hospital in the country to use Viz Aortic, an innovative artificial intelligence-powered software designed to detect abdominal aortic aneurysms (AAA).
An abdominal aortic aneurysm (AAA) is a bulging or ballooning in a portion of the aorta that runs through the abdomen. This bulge can break open, causing life-threatening internal bleeding if not caught in time. The cutting-edge Viz Aortic technology will help physicians identify patients with undiagnosed AAA, potentially saving lives.
“We are proud to be the first hospital in the U.S. to use Viz Aortic in our daily clinical practice,” said Philip M. Batista, MD, a vascular and endovascular surgeon at Cooper who led the clinical implementation of the new technology. “This technology will enable us to detect abdominal aortic aneurysms earlier, which can lead to improved surveillance, more thoughtful interventional planning, and ultimately lifesaving care.”
Snehal V. Gandhi, MD
“Our partnership with Viz.ai aligns with our commitment to delivering exceptional patient care by utilizing groundbreaking advancements in technology. This software holds immense potential for transforming the way we approach patient care,” said Snehal Gandhi, MD, chief medical information officer and medical director of Hospital Medicine at Cooper.
Viz Aortic uses artificial intelligence to automatically search for the presence of an abdominal aortic aneurysm from computed tomography angiography (CTA) from any scanner in a hospital network. The new artificial intelligence (AI) algorithm and clinical workflow solution will be a part of the Viz™ AORTIC Module, an AI solution designed to accelerate treatment decisions for all aortic pathology. Viz Aortic is designed to analyze CT scans for signs of aneurysms in real-time. The software uses advanced AI algorithms to identify subtle changes in the size and shape of the aorta, providing physicians with a powerful tool for early diagnosis and intervention.
“Our mission at Viz.ai is to increase patient access to lifesaving treatments,” said Jayme Strauss, chief clinical officer at Viz.ai. “We’re thrilled to expand our partnership with Cooper University Health Care into these critical vascular diseases and look forward to improving patient outcomes together.”
With Viz Aortic, Cooper University Health Care aims to improve the quality of care for patients with abdominal aortic aneurysms by enabling earlier detection and intervention. The health system will continue to evaluate the impact of the technology on patient outcomes and is committed to driving innovation in vascular care.
About Cooper University Health Care
Cooper University Health Care, with its MD Anderson Cancer Center at Cooper and affiliation with Cooper Medical School of Rowan University, is a leading academic health system. Cooper has more than 9,600 team members including 1,600 nurses, and more than 900 employed physicians and 450 advanced practice providers. Cooper University Hospital has been recognized as a top-performing regional hospital by U.S. News & World Report’s 2022-2023 Best Hospitals annual survey and has an “A”
Hospital Safety Grade from The Leapfrog Group, a national nonprofit upholding the standard of patient safety in hospitals and ambulatory surgery centers.
Cooper has revenues of more than $2 billion and has an “A-” rating from S&P Global Ratings and “A3” rating from Moody’s Investors Service. Cooper University Hospital is the only Level 1 Trauma Center in South Jersey and the busiest in the region. Nearly two million patients are served annually at Cooper’s 663-bed flagship hospital, outpatient surgery center, three urgent care centers, and more than 100 ambulatory offices throughout the community. Cooper has been named as one of America’s Best Employers by Forbes for two consecutive years.
The Cooper Health Sciences campus in Camden, New Jersey, is home to Cooper University Hospital, MD Anderson Cancer Center at Cooper, Children’s Regional Hospital at Cooper, and Cooper Medical School of Rowan University. Visit CooperHealth.org to learn more.
About Viz.ai
Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,300+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.